Effect of polyglutamylation of methotrexate on its accumulation and the development of resistance in the protozoan parasite Leishmania

被引:12
作者
El Fadili, A
Richard, D
Kündig, C
Ouellette, M [1 ]
机构
[1] CHUL, Ctr Rech, Ctr Rech Infectiol, Ste Foy, PQ G1V 4G2, Canada
[2] Univ Laval, Fac Med, Div Microbiol, Ste Foy, PQ G1V 4G2, Canada
基金
加拿大健康研究院;
关键词
drug accumulation; drug resistance; folate metabolism; folylpolyglutamate synthetase; Leishmania; methotrexate;
D O I
10.1016/S0006-2952(03)00417-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Folates are polyglutamylated in most organisms, and in cancer cells the polyglutamylation of folates and of the antifolate methotrexate (MTX) is an important determinant of MTX susceptibility. The folylpolyglutamate synthetase (FPGS) responsible for polyglutamylation of folates was recently characterized in the parasite Leishmania. We show here that MTX is polyglutamylated in Leishmania tarentolae and that triglutamates are the predominant form. The glutamate chain length of MTX increases significantly in Leishmania cells transfected with the FPGS gene and decreases in cells with one FPGS allele disrupted. Modulation in the expression of the FPGS gene also has a profound effect on MTX susceptibility and this effect was found to be dependent on the folate concentration of the medium. In the folate-rich medium SDM-79, overexpression of FPGS will confer MTX resistance while in M-199 medium, which has much less folates, FPGS transfectants are more sensitive to MTX. Cells with one allele of FPGS disrupted are more resistant to MTX in low folate medium. The modulation of FPGS expression affects both the short-term and long-term accumulation of folate and MTX, showing a marked decrease in accumulation in the FPGS haploid mutant. This differential accumulation was mediated by decreased influx of the drug into the cell. Finally, the analysis of MTX-resistant Leishmania mutants indicated that the presence of shorter glutamate chains on MTX is correlated with MTX resistance. (C) 2003 Elsevier Inc. All rights reserved.
引用
收藏
页码:999 / 1008
页数:10
相关论文
共 45 条
[1]  
ARREBOLA R, 1994, J BIOL CHEM, V269, P10590
[2]  
Backus HHJ, 2000, INT J CANCER, V87, P771, DOI 10.1002/1097-0215(20000915)87:6<771::AID-IJC2>3.0.CO
[3]  
2-V
[4]   PTR1 - A REDUCTASE MEDIATING SALVAGE OF OXIDIZED PTERIDINES AND METHOTREXATE RESISTANCE IN THE PROTOZOAN PARASITE LEISHMANIA-MAJOR [J].
BELLO, AR ;
NARE, B ;
FREEDMAN, D ;
HARDY, L ;
BEVERLEY, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (24) :11442-11446
[5]  
CALLAHAN HL, 1992, J BIOL CHEM, V267, P24165
[6]   Novel inhibitors of Leishmanial dihydrofolate reductase [J].
Chowdhury, SF ;
Di Lucrezia, R ;
Guerrero, RH ;
Brun, R ;
Goodman, J ;
Ruiz-Perez, LM ;
Pacanowska, DG ;
Gilbert, IH .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (08) :977-980
[7]  
Cole PD, 2001, CANCER RES, V61, P4599
[8]   Pteridine salvage throughout the Leishmania infectious cycle:: implications for antifolate chemotherapy [J].
Cunningham, ML ;
Beverley, SM .
MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2001, 113 (02) :199-213
[9]  
El Fadili A, 2002, MOL BIOCHEM PARASIT, V124, P63, DOI 10.1016/S0166-6851(02)00163-9
[10]  
ELLENBERGER TE, 1987, J BIOL CHEM, V262, P10053